Skip to main content

Botnar Research Center advancing research into coronavirus

| News

Botnar Research Center advancing research into coronavirus


The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

3D rendering of a microscopic image of the novel coronavirus SARS-CoV-2 (img: Creativeneko/123rf)

The Botnar Research Center for Child Health (BRCCH) was founded by the University of Basel and the Swiss Federal Institute of Technology in Zurich (ETH). The University Children’s Hospital Basel (UKBB) and the Swiss Tropical and Public Health Institute (Swiss TPH), which is likewise based in Basel, are also involved with the center. BRCCH is now providing its four partner institutions with 15 million Swiss francs to facilitate research into the coronavirus, as detailed in a press release issued by the University of Basel.

The funding is to be provided by the Foundation Botnar as part of a first emergency initiative organized by the BRCCH, which was opened in 2019. Within the framework of this initiative, projects “dealing with the diagnosis and human immune response to COVID-19, as well as to projects in the fields of medical interventions and disease management” are to be supported over the next two-and-a-half years.

The BRCCH initiative will focus on two objectives: first, to come up with solutions to urgent problems in the fight against the pandemic and, second, to develop long-term approaches “so that similar situations can be better managed worldwide in the future”.

Click here for other events that shaped the Basel Area in 2020

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.